Lucia Carrau

Postdoctoral Fellow


Dr. Carrau is a Uruguayan virologist with main expertise in emerging viruses and virus evolution. During her PhD she worked in in vitro and in vivo experimental evolution approaches on the picornavirus Coxsackievirus B3 and in the alphavirus chikungunya virus. This work led to the development of a novel live attenuated vaccine against chikungunya virus. For her next project she worked in the emerging arboviruses Mayaro and Usutu virus, considered to have high potential to cause outbreaks in the human population. In 2020 she joined the tenOever lab as a postdoctoral fellow, working mainly on animal models to study the host response and therapeutics against SARS-CoV-2. 


Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, Gilani A, Alvarez-Mulett S, Sholle ET, Chandar V, Bram Y, Hoffman K, Bhardwaj P, Piloco P, Rubio-Navarro A, Uhl S, Carrau L, Houhgton S, Redmond D, Shukla AP, Goyal P, Brown KA, tenOever BR, Alonso LC, Schwartz RE, Schenck EJ, Safford MM, Lo JC.

Cell Metablism 07/12/2021

PMID: 34879241

Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission

Horiuchi and Oishi et al.

Sci. Immunology 26/10/2021

Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2

Yang et al.

Stem Cell Reports 12/10/2021

Phylogenetic and genome wide deep sequencing analyses of canine parvovirus reveal co-infection with field variants and emergence of a recombinant strain.

Perez, R; Calleros, L; Marandino, A; Sarute, N; Iraola, G; Grecco, S; Blanc, H; Vignuzzi, M; Isakov, O; Shomron, N; Carrau, L; Hernández, M; Francia, L; Sosa, K; Tomás, G & Panzera, Y

PLoS ONE 02/12/2020

PMID: 25365348